dc.creator | Carlos Alberto González Delgado | |
dc.date.accessioned | 2018-10-18T20:12:51Z | |
dc.date.accessioned | 2022-10-13T19:45:06Z | |
dc.date.available | 2018-10-18T20:12:51Z | |
dc.date.available | 2022-10-13T19:45:06Z | |
dc.date.created | 2018-10-18T20:12:51Z | |
dc.identifier | 15250016 | |
dc.identifier | 10.1038/mt.2014.27 | |
dc.identifier | http://hdl.handle.net/11285/630309 | |
dc.identifier | 22 | |
dc.identifier | 7 | |
dc.identifier | 1310 | |
dc.identifier | 1319 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/4207752 | |
dc.publisher | Nature Publishing Group | |
dc.relation | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903759913&doi=10.1038%2fmt.2014.27&partnerID=40&md5=8f19aaba3365f84d7c33f08916ec8eb8 | |
dc.relation | Investigadores | |
dc.relation | Estudiantes | |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/4.0 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.source | Molecular Therapy | |
dc.subject | mammalian target of rapamycin | |
dc.subject | nanoparticle | |
dc.subject | paclitaxel | |
dc.subject | phosphatidylinositol 3 kinase | |
dc.subject | protein kinase B | |
dc.subject | rapamycin | |
dc.subject | paclitaxel | |
dc.subject | phosphatidylinositol 3 kinase | |
dc.subject | protein kinase B | |
dc.subject | rapamycin | |
dc.subject | target of rapamycin kinase | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | antineoplastic activity | |
dc.subject | breast cancer | |
dc.subject | cancer inhibition | |
dc.subject | conference paper | |
dc.subject | controlled study | |
dc.subject | drug delivery system | |
dc.subject | drug potentiation | |
dc.subject | drug tumor level | |
dc.subject | female | |
dc.subject | in vitro study | |
dc.subject | liver | |
dc.subject | mouse | |
dc.subject | nanoencapsulation | |
dc.subject | nanopharmaceutics | |
dc.subject | nonhuman | |
dc.subject | particle size | |
dc.subject | protein phosphorylation | |
dc.subject | protein targeting | |
dc.subject | spleen | |
dc.subject | animal | |
dc.subject | apoptosis | |
dc.subject | cell proliferation | |
dc.subject | drug effects | |
dc.subject | human | |
dc.subject | Mammary Neoplasms, Animal | |
dc.subject | MCF 7 cell line | |
dc.subject | metabolism | |
dc.subject | nude mouse | |
dc.subject | signal transduction | |
dc.subject | tumor cell line | |
dc.subject | Animalia | |
dc.subject | Mus | |
dc.subject | Animals | |
dc.subject | Apoptosis | |
dc.subject | Cell Line, Tumor | |
dc.subject | Cell Proliferation | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Mammary Neoplasms, Animal | |
dc.subject | MCF-7 Cells | |
dc.subject | Mice | |
dc.subject | Mice, Nude | |
dc.subject | Paclitaxel | |
dc.subject | Phosphatidylinositol 3-Kinases | |
dc.subject | Proto-Oncogene Proteins c-akt | |
dc.subject | Signal Transduction | |
dc.subject | Sirolimus | |
dc.subject | TOR Serine-Threonine Kinases | |
dc.title | Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway | |
dc.type | Conferencia | |